Impact of Red Blood Cell Alloimmunization in Patients with MDS, AML and CMML

Leisch M, Weiß L, Lindlbauer N, Rohde E, Greil R, Grabmer C, Pleyer L Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie; 07.-10.09.2016; Nürnberg. 2016.

3. Poast-SABCS 2015: Tumorinfiltrierende Lymphozyten, Immuntherapie und Gensignaturen

Gampenrieder, SP Jatros Hämatologie & Onkologie. 2016. 1: 90-93.

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.

Rawstron, AC; Fazi, C; Agathangelidis, A; Villamor, N; Letestu, R; Nomdedeu, J; Palacio, C; Stehlikova, O; Kreuzer, KA; Liptrot, S; O“Brien, D; de Tute, RM; Marinov, I; Hauwel, M; Spacek, M; Dobber, J; Kater, AP; Gambell, P; Soosapilla, A; Lozanski, G; Brachtl, G; Lin, K; Boysen, J; Hanson, C; Jorgensen, JL; Stetler-Stevenson, M; Yuan, C; Broome, HE; Rassenti, L; Craig, F; Delgado, J; Moreno, C; Bosch, F; Egle, A; Doubek, M; Pospisilova, S; Mulligan, S; Westerman, D; Sanders, CM; Emerson, R; Robins, HS; Kirsch, I; Shanafelt, T; Pettitt, A; Kipps, TJ; Wierda, WG; Cymbalista, F; Hallek, M; Hillmen, P; Montserrat, E; Ghia, P; Leukemia. 2016; 30(4):929-936

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.

Böll, B; Goergen, H; Behringer, K; Bröckelmann, PJ; Hitz, F; Kerkhoff, A; Greil, R; von Tresckow, B; Eichenauer, DA; Bürkle, C; Borchmann, S; Fuchs, M; Diehl, V; Engert, A; Borchmann, P; Blood. 2016; 127(18):218-292

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.

Suker, M; Beumer, BR; Sadot, E; Marthey, L; Faris, JE; Mellon, EA; El-Rayes, BF; Wang-Gillam, A; Lacy, J; Hosein, PJ; Moorcraft, SY; Conroy, T; Hohla, F; Allen, P; Taieb, J; Hong, TS; Shridhar, R; Chau, I; van Eijck, CH; Koerkamp, BG Lancet Oncol. 2016; 17(6):801-810

ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.

Krenn, PW; Hofbauer, SW; Pucher, S; Hutterer, E; Hinterseer, E; Denk, U; Asslaber, D; Ganghammer, S; Sternberg, C; Neureiter, D; Aberger, F; Wickström, SA; Egle, A; Greil, R; Hartmann, TN; Cancer Res. 2016; 76(8):218-296

The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.

Troppan, KT; Melchardt, T; Wenzl, K; Schlick, K; Deutsch, A; Bullock, MD; Reitz, D; Beham-Schmid, C; Weiss, L; Neureiter, D; Tränkenschuh, W; Greil, R; Neumeister, P; Egle, A; Pichler, M; J Clin Pathol. 2016; 69(4):326-330

Analysis of Ambient Influences Affecting Interleukin-6 Secretion in the Context of Clinical Trials of Stem Cell Therapy for Myocardial Infarction

Edlinger, C; Wernly, B; Leisch, M; Kammler, J; Kypta, A; Eder, S; Jung, C; Hoppe, UC; Lichtenauer, M CLIN LAB. 2016; 62(6): 1061-1068.

A diagnostic algorithm for the detection of inhibitors against coagulation Factor V.

Cadamuro, J; Skocic, M; Meisl, B; Raggam, RB; Felder, TK; Prüller, F; Reinstadler, K; Wiedemann, H; Mrazek, C; Clin Chem Lab Med. 2016; 54(7): e203-e206.

Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.

Hanna, BS; McClanahan, F; Yazdanparast, H; Zaborsky, N; Kalter, V; Rößner, PM; Benner, A; Dürr, C; Egle, A; Gribben, JG; Lichter, P; Seiffert, M; Leukemia. 2016; 30(3): 570-579.